WG
DCPH

Winton Group’s Deciphera Pharmaceuticals, Inc. Common Stock DCPH Stock Holding History

Winton Group’s Portfolio DCPH Stock Details DCPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-9,913
Closed -$337K – 1483
2021
Q3 		$337K Buy
+9,913
New +$316K 0.02% 1049
2020
Q4 		– Sell
-13,580
Closed -$697K – 1553
2020
Q3 		$697K Sell
13,580
-17,822
-57% -$873K 0.02% 971
2020
Q2 		$1.88M Buy
31,402
+15,841
+102% +$847K 0.05% 687
2020
Q1 		$641K Sell
15,561
-3,056
-16% -$170K 0.02% 962
2019
Q4 		$1.16M Buy
+18,617
New +$885K 0.02% 1012

Other funds holding DCPH

State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
NLVP
New Leaf Venture Partners New York $43M AUM 25.55% 1-Year Est. Return
Canada Pension Plan Investment Board
Canada Pension Plan Investment Board Toronto Ontario, Ontario, Canada $155B AUM 29.93% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return

Winton Group's DCPH Position: Q4 2021 in Review

Winton Group sold out of Deciphera Pharmaceuticals, Inc. Common Stock (DCPH) in Q4 2021, closing a stake of 9,913 shares — an estimated $337K sold.

Winton Group first reported a position in DCPH in Q4 2019 and held it in 5 quarters. The position peaked at $1.88M in Q2 2020. 140 funds tracked by Wall St. Rank hold DCPH as of Q4 2021.

  • Winton Group reported no remaining Deciphera Pharmaceuticals, Inc. Common Stock position as of Q4 2021 after selling out during the quarter.
  • Winton Group sold 9,913 Deciphera Pharmaceuticals, Inc. Common Stock shares in Q4 2021, an estimated $337K.
  • Winton Group first reported a position in Deciphera Pharmaceuticals, Inc. Common Stock in Q4 2019 and held it in 5 quarters.
  • Winton Group's Deciphera Pharmaceuticals, Inc. Common Stock position peaked at $1.88M in Q2 2020.
  • 140 funds tracked by Wall St. Rank held Deciphera Pharmaceuticals, Inc. Common Stock as of Q4 2021.

Based on Winton Group's 13F filing for Q4 2021, filed 10 Feb 2022.